Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oligoprogression in Non-Small Cell Lung Cancer.
Harada D, Takigawa N. Harada D, et al. Among authors: takigawa n. Cancers (Basel). 2021 Nov 20;13(22):5823. doi: 10.3390/cancers13225823. Cancers (Basel). 2021. PMID: 34830977 Free PMC article. Review.
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.
Nogami N, Hotta K, Segawa Y, Takigawa N, Hosokawa S, Oze I, Fujii M, Ichihara E, Shibayama T, Tada A, Hamada N, Uno M, Tamaoki A, Kuyama S, Ikeda G, Osawa M, Takata S, Tabata M, Tanimoto M, Kiura K. Nogami N, et al. Among authors: takigawa n. Acta Oncol. 2012 Jul;51(6):768-73. doi: 10.3109/0284186X.2011.648342. Epub 2012 Jan 27. Acta Oncol. 2012. PMID: 22283472 Clinical Trial.
JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation.
Harada D, Takigawa N, Ochi N, Ninomiya T, Yasugi M, Kubo T, Takeda H, Ichihara E, Ohashi K, Takata S, Tanimoto M, Kiura K. Harada D, et al. Among authors: takigawa n. Cancer Sci. 2012 Oct;103(10):1795-802. doi: 10.1111/j.1349-7006.2012.02363.x. Epub 2012 Jul 24. Cancer Sci. 2012. PMID: 22712764 Free PMC article.
Obstructive jaundice at the initial presentation in small-cell lung cancer.
Ochi N, Takigawa N, Yasugi M, Ishida E, Kawamoto H, Taniguchi A, Harada D, Hayashi E, Toda H, Yanai H, Tanimoto M, Kiura K. Ochi N, et al. Among authors: takigawa n. Int Med Case Rep J. 2010 Feb 25;3:9-12. doi: 10.2147/imcrj.s8093. Print 2010. Int Med Case Rep J. 2010. PMID: 23754881 Free PMC article.
The Role of STAT3 in Non-Small Cell Lung Cancer.
Harada D, Takigawa N, Kiura K. Harada D, et al. Among authors: takigawa n. Cancers (Basel). 2014 Mar 26;6(2):708-22. doi: 10.3390/cancers6020708. Cancers (Basel). 2014. PMID: 24675568 Free PMC article.
Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumors.
Yasugi M, Takigawa N, Ochi N, Ohashi K, Harada D, Ninomiya T, Murakami T, Honda Y, Ichihara E, Tanimoto M, Kiura K. Yasugi M, et al. Among authors: takigawa n. Exp Cell Res. 2014 Aug 15;326(2):201-9. doi: 10.1016/j.yexcr.2014.04.012. Epub 2014 Apr 25. Exp Cell Res. 2014. PMID: 24768699 Free article.
325 results